Announce your event here
US HUPO 14th Annual Conference Technology Accelerating Discovery
2018-03-11 to 2018-03-14
Minneapolis, MN, USA

The US HUPO annual conference has established itself as a highly valued contribution to the interdisciplinary scientific field of proteomics, with a particular focus on current technologies in the field and their application to solving biological and clinical questions relevant to human health. The topics covered at the annual conference reflect the multiple disciplines, strategies, and technologies encompassing the proteomics field, and their use to address complex biomedical problems and enable new discoveries aimed at advancing diagnosis, prognosis and treatment of human disease.

The title for US HUPO is Technology accelerating discovery, which encapsulates this interplay between technology (e.g. mass spectrometry, bioinformatics, clinical/cellular assays) and biological discovery inherent to the proteomics field.

We hope you will join us in Minneapolis next March.

http://www.ushupo.org/conference/generalinformation/tabid/63/default.aspxexternal link

11th Edition of International Conference on Proteomics
2018-03-22 to 2018-03-23
London, UK

Euroscicon Ltd like to take this opportunity to welcome all of you to “11th Edition of International Conference on Proteomics” which is to be held during March 22-23, 2018 at London, UK. Through our theme “Exploring Novel Drug in the Field of Proteomics”, the conference will analyse the recent advancements and new modes that can be enforced to the research to take Proteomics, one step further.

Proteomics Euroscicon 2018 will impact an attractive moment to meet people in the research field and therefore it takes a delight in opening a gate to meet the ability in the field, young researchers and potential speakers. The conference also includes essential topics on: Proteomics in Drug Discovery, Protein Expression and Analysis, Chromatin Proteomics, Protein Microarrays , The Cancer Proteome, Proteomics for Bioinformatics, Neuroproteomics, Proteomics and Cell Signalling, Metabolomics, Transcriptome Sequencing, Phylogenetic Analysis of Protein, Genomic, Proteomic and Metabolomic Data Integration Strategies and Molecular Docking and Structure-Based Drug Design Strategies.

Hence, we welcome you all to be a part of this event to contribute your novel research ideas.

The study of Proteomics is important as it represents the actual functional molecules in the cell. When mutations occurs in DNA, ultimately proteins are affected. . The major goal of proteomics study helps in understanding the function of proteins and their role by advance technology in order to find a novel drug. When pathogens infect, causing disease these proteins play a major role in signalling the presence & ridding us of these invaders. Almost in each and every process that occurs in our cells from the metabolisation of simple sugar to the distribution of cells is dependent on proteins for smooth operation. In general, proteomics seeks to disclose and quantify as many proteins as possible.

http://proteomics.euroscicon.com/external link

2018 Proteins & Antibodies Congress
2018-04-16 to 2018-04-17
London, UK

Oxford Global are pleased to announce the return of the Proteins & Antibodies Congress.

Taking place in London on 16-17 April 2018, this congress will be attended by 450+ senior level experts to network about the latest developments & participate in presentations from the below main themes:

• Protein Engineering, Design & Selection
• Antibody Engineering, Development & Design
• Cloning, Expression, Purification & Analytics
• Biotherapeutics: case studies, manufacturing challenges, chemistry, analytics & control

Programme Highlights Include:

• PD-1 Antibody: A Broad Spectrum Anti-Cancer Agent Both As Monotherapy And In Combination – Roy Baynes, Chief Medical Officer, Merck & Co., Inc.
• Developability Assessment Of Therapeutic Proteins – Thorsten Lorenz, Group Head, Novartis
• Integrated High Throughput Protein Purification & Analytics – Kenneth Walker, Director, Amgen
• Developing Bispecific Antibodies For Immuno-Oncology – Syd Johnson, Vice President, Macrogenics

Society members save 20% on the registration fee! Contact us at for the code.

https://www.proteins-congress.com/external link